Erratum: Activation of the IFN signaling pathway is associated with resistance to CDK4/6 inhibitors and immune checkpoint activation in ER-positive breast cancer (Clinical Cancer Research (2021) 27 (4870-4882) DOI: 10.1158/1078-0432.CCR-19-4191)

De Angelis, C.;Fu, X.;Cataldo, M. L.;Nardone, A.;Pereira, R.;Veeraraghavan, J.;Nanda, S.;Qin, L.;Sethunath, V.;Wang, T.;Hilsenbeck, S. G.;Benelli, M.;Migliaccio, I.;Guarducci, C.;Malorni, L.;Litchfield, L. M.;Liu, J.;Donaldson, J.;Selenica, P.;Brown, D. N.;Weigelt, B.;Reis-Filho, J. S.;Park, B. H.;Hurvitz, S. A.;Slamon, D. J.;Rimawi, M. F.;Jansen, V. M.;Jeselsohn, R.;Osborne, C. K.;Schiff, R.

2021-01-01